ArticleScientific reports2017

MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.

Chao Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.